Learn more about whether Alvotech or Grifols, S.A. is a better investment based on AAII's A+ Investor grades, which compare ...

CdM | Grifols shares lost more than 5% on the stock market on Monday. Last Friday, after the market had closed, a report was published by the National Securities Market Commission (CNMV) that was ...

Grifols announced on Thursday that it has signed a strategic agreement with Swiss laboratory automation firm Inpeco to provide automated instrumentation, robotics, and software to transfusion medicine ...

Grifols has signed a strategic agreement with Inpeco to provide transfusion medicine labs with complete, tailored ...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s ...

Spanish plasma-derived medicines specialist Grifols (MCE: GRF) has announced positive results from its Phase II/III clinical ...

Grifols, S.A. stock has a Value Grade of B. Vanda Pharmaceuticals Inc. stock has a Value Grade of B. Answer a few questions and we'll show you five of the highest-graded stocks that align with your ...

Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors ...

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols ...

Grifols (GRFS) issued a statement to address certain information published in a media outlet on March 8, specifically a front-page article titled “The CNMV reveals to the judge ‘continuous ...

Demonstrators marched outside the office of the Grifols Plasma Donation Centre, chanting slogans, carrying placards and blowing whistles as police officers watched nearby. "Not for sale!